Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Remission of rheumatoid arthritis linked with reduction in cardiovascular complications

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.

12 Jun 2019

Fibrinogen a key player in health and disease, says new study

A new study from the University of Alberta demonstrated that the blood clotting protein called fibrinogen also regulates MMP-2, an enzyme involved in immunity and in clot formation inside blood vessels. Prolonged MMP-2 inhibition could potentially produce a deficiency state with severe consequences.

12 Jun 2019

The immune system in women may be different from men finds study

Research has shown that women have a different immune system from men and may respond differently to different immune disease processes.

11 Jun 2019

Promising methods for early detection and treatment of rheumatoid arthritis

Rheumatoid arthritis is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs. In this themed issue of Clinical Therapeutics, published by Elsevier, experts review multiple aspects of RA detection and intervention with the overall goal of moving the field closer to developing effective preventive measures.

10 Jun 2019

Trump administration cracks down on fetal tissue research

The Trump administration is cutting funding for fetal tissue research despite opposition from scientists and clinicians.

10 Jun 2019

Allergies linked to higher junk food consumption, suggests new study

Many childhood food allergies could be due to eating junk food, according to a new study. Children with food allergies, and children who eat a lot of junk food, have increased body levels of molecules called advanced glycation end-products (AGEs).

10 Jun 2019

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

In a large-scale, international study led by renowned rheumatologist Josef Smolen from the Department of Medicine III, a still-to-be-approved drug containing the selective janus kinase inhibitor upadacitinib has proved itself to be a new option for treating active rheumatoid arthritis.

7 Jun 2019

New immunosuppressive regimens may improve outcomes for kidney transplant patients

Preliminary results from a $5.2 million clinical trial led by University of Cincinnati researchers show that the immunosuppressive drug belatacept can help safely and effectively treat kidney transplant patients without the negative long-term side effects of traditional immunosuppressive regimens, the study's leaders announced this week.

6 Jun 2019

Researchers develop NO-scavenging hydrogel for treatment of rheumatoid arthritis

Nitric oxide (NO) prevents high blood pressure and artery plaque build-up in our body. However, its duplicity is shown when it causes serious inflammatory disease such as systemic lupus erythematosus, Cronh's disease, and rheumatoid arthritis.

4 Jun 2019

Immune system discovery may lead to new models for diagnosing inflammatory diseases

A unique discovery about the nature of neutrophils -- the most numerous white blood cells in the body -- may lead to new models for diagnosing and tracking inflammatory diseases such as cancer and osteoarthritis.

30 May 2019

Newly identified internal regulator helps control body's response to fight infection

Scientists have identified a new internal regulator which helps control the body's response to fight infection.

30 May 2019

Scientists move a step closer to developing targeted therapies for inflammatory diseases

Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.

30 May 2019

Epigenetic research provides new approaches to cancer combination therapies

Epigenetic processes enable cells to respond to changes in their environment by regulating the activity of their genes.

28 May 2019

New study shows how a kidney biopsy can be used to tailor treatment for lupus patients

The kidneys of patients living with systemic lupus erythematosus are often under assault, and not all those living with the disease will respond to standard treatment.

21 May 2019

Researchers identify new molecular mechanism causing rheumatoid arthritis

A collaborative study by research groups from the University of Cologne, VIB, Ghent University, the Βiomedical Sciences Research Center 'Alexander Fleming' in Athens and the University of Tokyo identified a new molecular mechanism causing rheumatoid arthritis.

14 May 2019

New computational framework reveals impact of arthritis drugs on gene expression

A new computational framework has revealed key differences between four rheumatoid arthritis medications and their impact on biological pathways in mice.

10 May 2019

HSS researchers provide better understanding of the cellular mechanisms driving rheumatoid arthritis

Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior author Laura Donlin, PhD, Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery and collaborating colleagues.

10 May 2019

Long-standing immunosuppressive drug reduces Zika birth defects in mice

In experiments with pregnant mice infected with the Zika virus, Johns Hopkins Medicine researchers report they have successfully used a long-standing immunosuppressive drug to diminish the rate of fetal deaths and birth defects in the mice's offspring.

From Johns Hopkins Medicine 7 May 2019

Finding potential treatments for autoimmune diseases

More than 50 million Americans are affected by an autoimmune disease, with women at an increased risk for developing one.

7 May 2019

Klobuchar wants to stop ‘pay-for-delay’ deals that keep drug prices high

Washington's recent fixation with lowering drug costs has introduced Americans to once-insider terms like "pharmacy benefit managers" and "list prices."

26 Apr 2019

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Remission of rheumatoid arthritis linked with reduction in cardiovascular complications

Fibrinogen a key player in health and disease, says new study

The immune system in women may be different from men finds study

Promising methods for early detection and treatment of rheumatoid arthritis

Trump administration cracks down on fetal tissue research

Allergies linked to higher junk food consumption, suggests new study

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

New immunosuppressive regimens may improve outcomes for kidney transplant patients

Researchers develop NO-scavenging hydrogel for treatment of rheumatoid arthritis

Immune system discovery may lead to new models for diagnosing inflammatory diseases

Newly identified internal regulator helps control body's response to fight infection

Scientists move a step closer to developing targeted therapies for inflammatory diseases

Epigenetic research provides new approaches to cancer combination therapies

New study shows how a kidney biopsy can be used to tailor treatment for lupus patients

Researchers identify new molecular mechanism causing rheumatoid arthritis

New computational framework reveals impact of arthritis drugs on gene expression

HSS researchers provide better understanding of the cellular mechanisms driving rheumatoid arthritis

Long-standing immunosuppressive drug reduces Zika birth defects in mice

Finding potential treatments for autoimmune diseases

Klobuchar wants to stop ‘pay-for-delay’ deals that keep drug prices high

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in